TLR8 agonist 2 hydrochloride

Modify Date: 2024-10-12 10:01:54

TLR8 agonist 2 hydrochloride Structure
TLR8 agonist 2 hydrochloride structure
Common Name TLR8 agonist 2 hydrochloride
CAS Number 2412937-65-4 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula C16H22N8.xHCl Melting Point N/A
MSDS N/A Flash Point N/A

 Use of TLR8 agonist 2 hydrochloride


TLR8 agonist 2 hydrochloride is a potent and selective TLR8 agonist with an EC50 of 3 nM for human TLR8. TLR8 agonist 2 hydrochloride shows less active against human TLR7 (EC50 of 33.33 μM)[1].

 Names

Name TLR8 agonist 2 hydrochloride

 TLR8 agonist 2 hydrochloride Biological Activity

Description TLR8 agonist 2 hydrochloride is a potent and selective TLR8 agonist with an EC50 of 3 nM for human TLR8. TLR8 agonist 2 hydrochloride shows less active against human TLR7 (EC50 of 33.33 μM)[1].
Related Catalog
Target

TLR8:3 nM (EC50)

TLR7:33.33 μM (EC50)

In Vitro TLR8 agonist 2 (Example 1) increases the levels of TNF-α, IL-12p40, IFN-γ, and IFN-α with EC50 values 105 nM, 26 nM, 29 nM, and 2800 nM, respectively, in human peripheral blood mononuclear cells (hPBMC)[1].
In Vivo The pharmacokinetic related parameters of TLR8 agonist 2 (Example 1) in mice administered with the intravenous administration of 1 mg/kg and the oral administration of 5 mg/kg are detected. The T1/2 of TLR8 agonist 2 are 0.25 h (1 mg/kg i.v.) and 0.5 h (5 mg/kg p.o.), the AUClast are 450 ng/mL*hr (i.v.) and 624 ng/mL*hr (p.o.). And for oral administration, the bioavailability (%F) is 27.7%[1]
References

[1]. Zhe Cai, et al. Tlr8 agonist. WO2020057604A1.

 Chemical & Physical Properties

Molecular Formula C16H22N8.xHCl
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

TLR8 agonist 2 hydrochloride suppliers

TLR8 agonist 2 hydrochloride price

Related Compounds: More...
TLR8 agonist 2
2412937-64-3
Tridecyl 2-Aminoacetate Hydrochloride
94856-88-9
(2R)-2-Morpholinylmethanol hydrochloride (1:1)
156925-22-3
methyl 2-cyanoacetimidate hydrochloride
53557-70-3
Ethanimidamide,2-(phenylmethoxy)-, hydrochloride (1:1)
22018-43-5
ethyl 2-phenoxysulfonylethanimidate,hydrochloride
646053-35-2
Cyclohexanamine,2-chloro-, hydrochloride (1:1), (1R,2S)-rel-
5204-79-5
1,2-diphenylguanidine,hydrochloride
52392-53-7
Dimethyl 2-vinylglutamate hydrochloride
70805-20-8
Arsenic, bis(mu-(bis(trimethylsilyl)orthoarsenato-O'':O'''))di-mu-oxotetrakis(trimethylsilanolato)di-
137823-45-1
Sodium;7-[[2-(carbamoylamino)-4-[[4-[3-[[4-[3-(carbamoylamino)-4-[(3,6,8-trisulfonaphthalen-2-yl)diazenyl]anilino]-6-fluoro-1,3,5-triazin-2-yl]amino]propylamino]-6-fluoro-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]naphthalene-1,3,6-trisulfonic acid
143683-24-3
Mono(1-nitroso-2-pyrrolidinyl) ester 5'-thymidylic acid
152230-94-9
3-(4-(methoxymethyl)-1H-1,2,3-triazol-1-yl)-N-(4-(trifluoromethyl)phenyl)pyrrolidine-1-carboxamide
2320415-43-6
3-{[1-(4-Chlorobenzoyl)piperidin-4-yl]methoxy}-5,6,7,8-tetrahydrocinnoline
2320885-41-2
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-3'-O-[(1,1-dimethylethyl)diphenylsilyl]-N-(2-methyl-1-oxopropyl)Guanosine
166758-17-4
7-Amino-4-hydroxy-3,8-bis[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-2-naphthalenesulfonic acid
177964-22-6
2-(2,6-Diamino-9H-purin-9-yl)ethan-1-ol hydrochloride
2171835-13-3
2-Propenoic acid, 3-[2-[2-[4-[bis(3-methoxy-3-oxopropyl)amino]-2-hydroxyphenyl]diazenyl]-4-chloro-5-thiazolyl]-2-cyano-, hexyl ester
1114964-27-0
2-Ethyl-4-methyl-6-(piperazin-1-YL)pyrimidine dihydrochloride
2323071-17-4